Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia

医学 四分位间距 队列 抗精神病药 精神分裂症(面向对象编程) 精神科 儿科 队列研究 人口 内科学 环境卫生
作者
Cheng-Yi Huang,Su‐Chen Fang,Yu‐Hsuan Joni Shao
出处
期刊:JAMA network open [American Medical Association]
卷期号:4 (5): e218810-e218810 被引量:54
标识
DOI:10.1001/jamanetworkopen.2021.8810
摘要

Schizophrenia is generally considered to be among the most severe psychiatric disorders because of the excessive mortality associated with it. Research to find means to reduce this excessive mortality is warranted.To investigate associations of long-acting injectable antipsychotics (LAIs) with all-cause, natural-cause, and suicide mortality risks as well as the impacts of early use of LAIs in patients with newly diagnosed schizophrenia.This cohort study used data from the Taiwan National Health Insurance Research Database to construct a population-based cohort of patients with schizophrenia who received oral antipsychotics (OAPs) from January 1, 2002, to December 31, 2017. Within this cohort, the LAI group was defined as patients who switched to LAIs and were prescribed LAIs at least 4 times within 1 year. The LAI group was propensity matched 1:1 to patients who continued receiving OAPs of the same compounds. All patients were followed up until switching the antipsychotic administration route, death, or the end of the study (December 31, 2018), whichever occurred first. Data analysis was performed from January 2002 to December 2018.All-cause mortality, natural-cause mortality, suicide mortality, and suicide attempts.In total, 2614 patients who switched to LAIs (median [interquartile range] {IQR} age, 30 [23-39] years) and 2614 who received OAPs (median [IQR] age, 30 [23-39] years) were included (1333 male patients [51.0%] in each group). During the 16-year follow-up period (median [IQR] follow-up of 14 [10-17] years), patients who switched to LAIs had lower risks of all-cause mortality (adjusted hazard ratio [aHR], 0.66; 95% CI, 0.54-0.81), natural-cause mortality (aHR, 0.63; 95% CI, 0.52-0.76), and suicide attempts (incidence rate ratio, 0.72; 95% CI, 0.55-0.93) compared with patients who received the corresponding OAPs. A 47% lower suicide mortality risk (aHR, 0.53; 95% CI, 0.30-0.92) was observed in patients who switched to LAIs within the first 2 years of OAP initiation.These findings suggest that LAI use in patients with newly diagnosed schizophrenia is associated with decreased all-cause mortality and suicide risk. Furthermore, early treatment with LAIs within the first 2 years of OAP initiation was associated with a decrease in suicide mortality risk. Thus, LAI use in the early stage of treatment should be actively considered for patients with newly diagnosed schizophrenia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dongdong完成签到 ,获得积分10
刚刚
四叶草完成签到 ,获得积分10
1秒前
崔秀萍完成签到 ,获得积分10
2秒前
6秒前
水煮电吹风的应助被Albafika采纳,获得10
7秒前
rzxhygr完成签到,获得积分10
9秒前
江海阔完成签到,获得积分10
11秒前
高贵嘉懿完成签到,获得积分10
12秒前
超帅晓槐完成签到,获得积分10
13秒前
长情以蓝完成签到 ,获得积分10
13秒前
紫熊发布了新的文献求助10
18秒前
24秒前
儒雅傲之完成签到,获得积分10
25秒前
河不柃完成签到,获得积分10
26秒前
wwwwcom完成签到,获得积分10
28秒前
小刺猬完成签到,获得积分10
29秒前
沉静的便当完成签到 ,获得积分10
29秒前
Flying_Time完成签到,获得积分10
30秒前
哈哈哈完成签到,获得积分10
31秒前
jazz完成签到,获得积分10
32秒前
33秒前
asdf完成签到,获得积分10
33秒前
Xiao_Fu完成签到,获得积分10
34秒前
Adrianlee完成签到,获得积分10
35秒前
SCIReader1112完成签到,获得积分10
35秒前
王继完成签到,获得积分10
36秒前
lblb完成签到,获得积分10
36秒前
xxx完成签到,获得积分10
36秒前
想毕业的笑笑完成签到,获得积分10
37秒前
MaxwellZH完成签到,获得积分10
37秒前
卡片完成签到,获得积分10
38秒前
混子完成签到,获得积分10
38秒前
胡思乱响完成签到,获得积分10
39秒前
怕黑的店员完成签到,获得积分10
40秒前
40秒前
星司完成签到,获得积分10
40秒前
hahaha6789y完成签到,获得积分10
41秒前
舒心的夜完成签到,获得积分10
41秒前
英语小A完成签到,获得积分10
41秒前
想毕业的猫猫完成签到,获得积分10
41秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185520
求助须知:如何正确求助?哪些是违规求助? 9574253
关于积分的说明 21834635
捐赠科研通 7783146
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558951
邀请新用户注册赠送积分活动 2481357